MLAB (STOCKS)
Mesa Laboratories Inc
$113.200000
+0.400000 (+0.35%)
Prev close: $112.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Siddhartha C. Kadia
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $684.22M
- Employees
- 730
- P/E (TTM)
- 133.46
- P/B (TTM)
- 3.34
- Dividend Yield
- 56.74%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q1)
|
$2.61 | $0.03 | +2.5794 | +8,429.41% |
|
Mar 2026 (Q4)
|
$-0.75 | $0.35 | -1.0968 | -316.26% |
|
Dec 2025 (Q3)
|
$0.65 | $0.28 | +0.3678 | +130.33% |
|
Sep 2025 (Q2)
|
$0.45 | $0.16 | +0.2868 | +175.74% |
Financial Statements
| Revenues | $249.73M |
| Benefits Costs and Expenses | $240.37M |
| Cost Of Revenue | $89.38M |
| Costs And Expenses | $240.37M |
| Gross Profit | $160.34M |
| Nonoperating Income/Loss | -$13.12M |
| Operating Expenses | $137.87M |
| Research and Development | $20.05M |
| Other Operating Expenses | $117.82M |
| Operating Income/Loss | $22.48M |
| Income/Loss From Continuing Operations After Tax | $10.10M |
| Income/Loss From Continuing Operations Before Tax | $9.36M |
| Income Tax Expense/Benefit | $4.56M |
| Net Income/Loss | $4.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $4.80M |
| Net Income/Loss Available To Common Stockholders, Basic | $4.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.86 |
| Diluted Earnings Per Share | $0.85 |
| Basic Average Shares | 16,711,000 |
| Diluted Average Shares | 16,870,000 |
| Common Stock Dividends | $0.64 |
| Assets | $419.22M |
| Current Assets | $102.85M |
| Inventory | $27.23M |
| Other Current Assets | $75.62M |
| Noncurrent Assets | $316.38M |
| Fixed Assets | $30.09M |
| Other Non-current Assets | $286.29M |
| Liabilities | $230.46M |
| Current Liabilities | $57.32M |
| Accounts Payable | $7.46M |
| Wages | $13.18M |
| Other Current Liabilities | $36.68M |
| Noncurrent Liabilities | $173.14M |
| Long-term Debt | $66.09M |
| Other Non-current Liabilities | $107.05M |
| Equity | $188.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $188.76M |
| Liabilities And Equity | $419.22M |
| Net Cash Flow From Operating Activities | $55.67M |
| Net Cash Flow From Operating Activities, Continuing | $55.67M |
| Net Cash Flow From Investing Activities | -$2.80M |
| Net Cash Flow From Investing Activities, Continuing | -$2.80M |
| Net Cash Flow From Financing Activities | -$43.93M |
| Net Cash Flow From Financing Activities, Continuing | -$43.93M |
| Net Cash Flow | $8.95M |
| Net Cash Flow, Continuing | $8.95M |
| Comprehensive Income/Loss | $3.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $4.41M |
| Other Comprehensive Income/Loss | $1.37M |